Evommune EVMN Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Evommune in its filing.
Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation.
The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evommune 's stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Evommune 's stock issuance proceeds?
- Evommune (EVMN) reported stock issuance proceeds of $123.29K in Q1 2026.
- How has Evommune 's stock issuance proceeds changed year-over-year?
- Evommune 's stock issuance proceeds decreased by 51.3% year-over-year, from $252.9K to $123.29K.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.